Background illustration for clinical trials search

Paid Clinical Trials Calgary

Discover 521 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

for
Hodgkin Lymphoma
Location: Calgary, Regina, Vancouver, London, Hamilton, Toronto,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05180097

Phase 2, Recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for
Breast Cancer
Location: Calgary, Edmonton, Everett WA, Seattle WA, Edmonds WA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06790693

Phase 3, Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Calgary, Spokane WA, Denver CO, La Jolla CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase 2, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Calgary, Edmonton, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase 2, Recruiting

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: Calgary, Tacoma WA, Boise ID, Portland OR, Eugene OR,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06806033

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Calgary, Edmonton, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase 2, Recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

for
Metastatic Colorectal Cancer
Location: Calgary, Saskatoon, Regina, Los Alamitos CA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06252649

Phase 3, Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Calgary, Edmonton, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase 2, Phase 3, Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Calgary, Edmonton, Bellevue WA, Winnipeg, Aurora CO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase 3, Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Calgary, Vancouver, Seattle WA, Winnipeg,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase 2, Recruiting

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

for
Brain Metastases
Location: Calgary, Edmonton, Great Falls MT, Vancouver,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03550391

Phase 3, Recruiting
New

ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

for
Stroke, Acute Ischemic, Endovascular Thrombectomy,
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07687056

Phase 3, Recruiting

Rapid, Accurate, Cost-effective Assessment of Blood Biomarkers for Diagnosis of Concussion

for
Concussion, Mild
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 65

Code: NCT05588115

Recruiting

Valvular Surgery: Minimally Invasive vs Conventional Sternotomy

for
Minimally Invasive Cardiac Valvular Surgery
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT04514315

Recruiting

Therapeutic Plasma Exchange in Septic Shock: A Pilot Study

for
Septic Shock
Location: Calgary, Edmonton, Winnipeg, Hamilton, Toronto, Ottawa,
Sponsor: University of Manitoba

Sex: All

Age: 16+

Code: NCT05093075

Phase 2, Recruiting

Alberta Collaborative QI Strategies to Improve Outcomes of Moderate and Late Preterm Infants (ABC-QI Trial)

for
Length of Stay
Location: Calgary, Red Deer, Lethbridge, Medicine Hat, Edmonton
Sponsor: University of Calgary

Sex: All

Age: 0

Code: NCT05231200

Recruiting

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

for
Staphylococcus Aureus Bacteremia,
Location: Calgary, Surrey, Hamilton, Saint Catharines, Ottawa,
Sponsor: Todd C. Lee MD MPH FIDSA

Sex: All

Age: 18 - 70+

Code: NCT04886284

Phase 2, Recruiting

Minocycline in Acute Spinal Cord Injury (MASC)

for
Spinal Cord Injuries
Location: Calgary, Edmonton, London
Sponsor: Rick Hansen Institute

Sex: All

Age: 16+

Code: NCT01828203

Phase 3, Recruiting

Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid Hemorrhage

for
Aneurysmal Subarachnoid Hemorrhage, Intraventricular Hemorrhage
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT01098890

Phase 2, Recruiting

The Management of Traumatic Hemothoraces

for
Hemothorax, Thoracic Injuries
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 70+

Code: NCT03050502

Recruiting